Vectura News Discover more about our company, science, innovation and people with the latest headlines from Vectura.
Vectura Signs Pre-Clinical Development Agreement with Incannex to Advance IHL-216A for the Treatment of Traumatic Brain Injury Published22/06/2021 Read more
Vectura announces completion of management buy-out of Lyon oral subsidiary, Skyepharma Production SAS Published10/06/2021 Read more
Vectura and Inspira Pharmaceuticals Sign Agreement to Develop Potential Inhaled Treatment for COVID-19 Published06/05/2021 Read more
Showcasing our scientific expertise at Respiratory Drug Delivery Congress (RDD) 4th-7th May, 2021 Published28/04/2021 Read more
Vectura highlights update made by Hikma on launch of generic Advair Diskus® Published21/04/2021 Read more
“Strategies for rapid progression of inhaled products” at Formulation & Delivery Europe Congress: Online Published15/04/2021 Read more
